Biotechnology: Pharmaceutical Preparations Stocks
436 biotechnology: pharmaceutical preparations stocks ranked by market capitalization, page 6 of 9. Updated October 11, 2026.
Today
+1.28%Biotechnology: Pharmaceutical Preparations stocks ranked 251–300
| # | Symbol | Company | Price | % Change | Volume | Market Cap |
|---|---|---|---|---|---|---|
| 251 | PRQR | ProQR Therapeutics N.V. | 1.63 | +3.82% | 676.09K | $230.02M |
| 252 | EVMN | Evommune Inc. | 6.25 | -2.50% | 557.95K | $226.83M |
| 253 | NATR | Nature's Sunshine Products Inc. | 12.64 | +0.56% | 75.89K | $222.41M |
| 254 | SION | Sionna Therapeutics Inc. | 4.90 | 0.00% | 633.56K | $221.24M |
| 255 | ADCT | ADC Therapeutics SA | 1.73 | +8.80% | 3.10M | $220.87M |
| 256 | TRDA | Entrada Therapeutics Inc. | 5.67 | +2.53% | 209.36K | $220.77M |
| 257 | RNAC | Cartesian Therapeutics Inc. | 7.06 | +3.45% | 114.55K | $213.45M |
| 258 | LYEL | Lyell Immunopharma Inc. | 8.71 | -0.91% | 106.81K | $213.44M |
| 259 | ELDN | Eledon Pharmaceuticals Inc. | 2.48 | +2.48% | 818.75K | $201.53M |
| 260 | CUE | Cue Biopharma Inc. | 27.66 | +23.87% | 394.67K | $200.93M |
| 261 | WHWK | Whitehawk Therapeutics Inc. | 3.52 | +1.44% | 320.26K | $200.67M |
| 262 | NGEN | NervGen Pharma Corp. | 1.73 | -1.14% | 293.22K | $186.01M |
| 263 | ADAG | Adagene Inc. ADR | 2.76 | -0.72% | 1.65M | $185.32M |
| 264 | YARW | Yarrow Bioscience Inc. | 19.71 | -0.81% | 162.19K | $183.39M |
| 265 | PEPG | PepGen Inc. | 2.62 | +10.08% | 603.87K | $181.22M |
| 266 | ORMP | Oramed Pharmaceuticals Inc. | 4.33 | +3.10% | 193.50K | $180.12M |
| 267 | VRXA | Veraxa Biotech AG | 1.26 | +15.60% | 1.86M | $178.17M |
| 268 | DERM | Journey Medical Corporation | 6.31 | +6.05% | 156.94K | $178.10M |
| 269 | ALXO | ALX Oncology Holdings Inc. | 1.25 | +5.93% | 1.22M | $172.85M |
| 270 | CNTN | Canton Strategic Holdings Inc. | 2.11 | +1.44% | 726.15K | $168.13M |
| 271 | ANTX | AN2 Therapeutics Inc. | 4.40 | -5.98% | 442.13K | $166.04M |
| 272 | ORGO | Organogenesis Holdings Inc. Class A | 1.29 | +0.78% | 402.07K | $165.99M |
| 273 | EMIS | Emmis Acquisition Corp. Class A | 10.27 | 0.00% | 6 | $162.02M |
| 274 | NBP | NovaBridge Biosciences ADR | 1.40 | +1.82% | 295.92K | $161.82M |
| 275 | NKTX | Nkarta Inc. | 2.25 | +1.35% | 904.87K | $161.16M |
| 276 | MENS | Jyong Biotech Ltd. | 2.10 | 0.00% | 36.71K | $159.66M |
| 277 | MSLE | Satellos Bioscience Inc. | 7.49 | +1.97% | 59.90K | $158.91M |
| 278 | NERV | Minerva Neurosciences Inc | 3.18 | -1.24% | 192.50K | $151.84M |
| 279 | TLSA | Tiziana Life Sciences Ltd. | 1.19 | +5.31% | 2.42M | $151.44M |
| 280 | KRRO | Korro Bio Inc. | 10.16 | -3.97% | 133.51K | $149.61M |
| 281 | RNA | Atrium Therapeutics Inc. | 8.40 | +1.69% | 208.35K | $143.69M |
| 282 | BGM | BGM Group Ltd. Class A | 10.75 | +10.94% | 3.10K | $143.56M |
| 283 | CLLS | Cellectis S.A. ADR | 1.26 | +0.80% | 75.76K | $126.92M |
| 284 | SPRB | Spruce Biosciences Inc. | 44.05 | -3.27% | 83.76K | $126.60M |
| 285 | TNXP | Tonix Pharmaceuticals Holding Corp. | 7.30 | +0.27% | 963.56K | $125.20M |
| 286 | HURA | TuHURA Biosciences Inc. | 1.96 | +1.55% | 148.97K | $124.90M |
| 287 | NRXP | NRX Pharmaceuticals Inc. | 2.85 | -1.38% | 289.40K | $123.39M |
| 288 | VTVT | vTv Therapeutics Inc. Class A | 31.18 | +3.66% | 12.84K | $123.28M |
| 289 | INO | Inovio Pharmaceuticals Inc. | 1.15 | +5.50% | 2.89M | $118.91M |
| 290 | FHTX | Foghorn Therapeutics Inc. | 2.00 | +0.50% | 646.95K | $118.77M |
| 291 | COYA | Coya Therapeutics Inc. | 4.95 | -0.80% | 151.83K | $116.12M |
| 292 | GNLX | Genelux Corporation | 2.56 | +2.40% | 154.65K | $115.83M |
| 293 | PMVP | PMV Pharmaceuticals Inc. | 1.52 | +2.01% | 891.74K | $114.78M |
| 294 | QUCY | Quantum Cyber N.V. | 1.35 | -2.88% | 637.10K | $113.49M |
| 295 | UNCY | Unicycive Therapeutics Inc. | 4.11 | +0.98% | 551.39K | $112.59M |
| 296 | IMUX | Immunic Inc. | 8.19 | +8.33% | 512.18K | $111.75M |
| 297 | CPIX | Cumberland Pharmaceuticals Inc. | 7.03 | +0.72% | 30.40K | $105.33M |
| 298 | AARD | Aardvark Therapeutics Inc. | 4.76 | +1.06% | 140.86K | $104.17M |
| 299 | CRBP | Corbus Pharmaceuticals Holdings Inc. | 5.38 | +2.09% | 872.80K | $104.06M |
| 300 | BMEA | Biomea Fusion Inc. | 1.42 | +3.65% | 1.17M | $102.67M |
Explore more
Prices as of Oct 11, 4:30 PM EDT. Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer